In diseases including glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD), where oxidative stress and neuroinflammation play significant roles, iNOS expression contributes to neuronal damage and disease progression, leading to impaired visual function [54,55]. Here, NOS2 is linked to glaucoma.